Your Source For Immunology Laboratory Information
Issue 1. Vol. 1 June 2019
Anti-CarP & Other Biomarkers for Diagnosis & Prognosis of Rheumatoid Arthritis
For patients with rheumatoid arthritis (RA), treating the disease early and appropriately is essential for the best chance of remission or comfortable management. 1 Not all cases of RA are identical, however. Clinical features and prognosis of each patient’s case help inform the best course of treatment for the individual. There are a few biological markers, measured by a blood test, which indicate a poor prognosis and the necessity for more robust treatment, such as biological therapy.1,2
New AVISE SLE Monitor Test Incorporates A Powerful Combination of Biomarkers to Provide Actionable Results – A Case Study
A 57-year-old African American female with SLE was under the care of Dr. Macalester and started complaining of worsening symptoms despite being on 200 mg of HCQ. The patient had a medical history of fatigue, multiple miscarriages, myeloproliferative disorder and multiple positive ENA antibodies. To help assess the patient’s disease activity and HCQ adherence, Dr. Macalester ordered the AVISE SLE Monitor test including HCQ measurement. Test results revealed...
HIGH TECH HIGHLIGHT
High Tech ANA Testing
Lab testing for antinuclear antibodies (ANA) is a relatively old test with its origins dating back to 1950. Even so, the ANA test has stood the test of time and remains regarded as the gold standard screening assay for systemic autoimmune conditions. Advances in computer aided instrumentation, specifically digital microscopy, have recently ushered in a new era for the old ANA test helping to address many longstanding shortcomings of that approach.